Home › Funds › T. Rowe Price › T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
Fund family: T. Rowe Price · Filed by T. Rowe Price Integrated Equity Funds, Inc. (CIK 1038469) · SEC series S000002074
Share classes and tickers: PRDSX (C000005434), TQAAX (C000170855), TQAIX (C000169956)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,621 with, 9 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 3 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | T. Rowe Price | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 89.7% | 2,560 | 93.7% | 208,710 |
| Backed environmental and social shareholder proposals at US companies | n/a | 3 | 2.6% | 3,333 |
Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most T. Rowe Price funds on 53 items (2.2% of the 2,416 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Birkenstock Holding Plc | 2026-04-29 | Amend Articles of Association | For | AGAINST — 11 of 14 T. Rowe Price funds | For | — |
| Birkenstock Holding Plc | 2026-04-29 | Elect Director Ruth Kennedy | For | AGAINST — 11 of 14 T. Rowe Price funds | For | — |
| Cytokinetics, Incorporated | 2026-05-27 | 2 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. | Withhold | FOR — 15 of 22 T. Rowe Price funds | Against | Passed (calculated), 97.0% support |
| Adaptive Biotechnologies Corporation | 2026-06-05 | To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MD | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | — |
| IonQ, Inc. | 2026-06-16 | To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. Chou | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Elected, 71.3% support |
| IonQ, Inc. | 2026-06-16 | To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. Scannell | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Elected, 83.0% support |
| Kadant Inc. | 2026-05-20 | Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. Leonard | Against | FOR — 6 of 8 T. Rowe Price funds | Against | — |
| Element Solutions Inc | 2026-05-04 | Election of Directors: E. Stanley O'Neal | For | AGAINST — 7 of 10 T. Rowe Price funds | For | Passed (calculated), 94.2% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Patrick M. Dewar | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 96.4% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Vinod M. Khilnani | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 96.6% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: D. Jeffrey Richardson | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 89.0% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: Elizabeth M. Schwarting | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 80.4% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander Plouffe | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 99.5% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha Sankaran | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 99.7% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen III | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 96.9% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Abid Rizvi | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Alissa Ahlman | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Mary Baglivo | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Richard Zannino | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 95.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Robert Fisch | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.3% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stanley Fleishman | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 90.7% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stephen White | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.5% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Thomas Hendrickson | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.0% support |
| Element Solutions Inc | 2026-05-04 | Advisory vote to approve the Company's 2025 executive compensation | Against | FOR — 8 of 13 T. Rowe Price funds | Against | Failed (calculated), 41.4% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Todd Penegor | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 91.7% support |
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Travis Boersma | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 95.6% support |
| Almonty Industries Inc. | 2026-06-09 | Elect Director Andrew Frazer | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Almonty Industries Inc. | 2026-06-09 | Elect Director Daniel D'Amato | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Almonty Industries Inc. | 2026-06-09 | Elect Director David Hanick | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Almonty Industries Inc. | 2026-06-09 | Elect Director Lewis Black | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Almonty Industries Inc. | 2026-06-09 | Elect Director Mark Trachuk | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Advanced Energy Industries, Inc. | 2026-05-07 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; and | Against | FOR — 6 of 9 T. Rowe Price funds | Against | Approved, 78.4% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Amin N. Maredia | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Edward N. Antoian | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 97.6% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Harry S. Cherken, Jr. | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.4% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: John C. Mulliken | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 97.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Kelly Campbell | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 99.3% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Mary C. Egan | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Todd R. Morgenfeld | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 99.1% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Wesley S. McDonald | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.3% support |
| Interparfums, Inc. | 2025-09-10 | To vote for the advisory resolution to approve executive compensation. | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Approved, 84.3% support |
| Marqeta, Inc. | 2026-06-10 | To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law. | For | AGAINST — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 78.7% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) Li | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 92.2% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha Cummings | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 82.1% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma Atkinson | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 87.8% support |
| Marqeta, Inc. | 2026-06-10 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | For | AGAINST — 8 of 14 T. Rowe Price funds | For | Passed (calculated), 78.5% support |
| MapLight Therapeutics, Inc. | 2026-06-23 | To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin Babler | For | WITHHOLD — 8 of 14 T. Rowe Price funds | For | — |
| Installed Building Products, Inc. | 2026-05-19 | Election of Directors to serve for three-year terms: Robert H. Schottenstein | Against | FOR — 7 of 12 T. Rowe Price funds | Against | Elected, 93.9% support |
| Xenon Pharmaceuticals Inc. | 2026-06-02 | To approve the Corporation's 2026 Equity Incentive Plan; | Against | FOR — 7 of 12 T. Rowe Price funds | Against | Approved, 68.0% support |
| Kodiak Sciences Inc. | 2026-06-02 | Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. Bancroft | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 78.7% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: David Schenkein, M.D. | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 73.5% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: Jennifer Cook | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 60.9% support |
| Impinj, Inc. | 2026-05-28 | Election of Directors: Steve Sanghi | For | AGAINST — 7 of 13 T. Rowe Price funds | For | Elected, 68.1% support |
Download all 53 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 94.2% of this fund’s 2,630 such votes could be given a sector; the other 153 (5.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 588 | 1 | 0.2% |
| Consumer Discretionary | 534 | 2 | 0.4% |
| Industrials | 447 | 4 | 0.9% |
| Technology | 422 | 2 | 0.5% |
| Finance | 181 | 0 | 0.0% |
| Real Estate | 96 | 0 | 0.0% |
| Energy | 83 | 0 | 0.0% |
| Consumer Staples | 38 | 0 | 0.0% |
| Miscellaneous | 37 | 0 | 0.0% |
| Basic Materials | 34 | 0 | 0.0% |
| Telecommunications | 13 | 0 | 0.0% |
| Utilities | 4 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,815 | 0 |
| Say-on-Pay | 315 | 0 |
| Audit-related | 312 | 0 |
| Compensation | 96 | 0 |
| Corporate Governance | 55 | 5 |
| Capital Structure | 35 | 0 |
| Extraordinary Transactions | 15 | 0 |
| Shareholder Rights and Defenses | 11 | 1 |
| Other Social Issues | 2 | 1 |
| Diversity, Equity, and Inclusion | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Bloom Energy Corporation | May 21, 2026 | $135M | 8 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $125M | 5 | 0 |
| BrightSpring Health Services, Inc. | May 21, 2026 | $114M | 5 | 0 |
| Rambus Inc. | April 23, 2026 | $94M | 6 | 0 |
| Watts Water Technologies, Inc. | May 19, 2026 | $92M | 11 | 0 |
| InterDigital, Inc. | June 10, 2026 | $87M | 11 | 0 |
| Applied Industrial Technologies, Inc. | October 21, 2025 | $83M | 5 | 0 |
| Carpenter Technology Corporation | October 7, 2025 | $82M | 5 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| September 3, 2025 | Casey's General Stores, Inc. | Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposal | Against | For |
| May 6, 2026 | Entegris, Inc. | Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposal | Against | For |
| May 11, 2026 | MKS Inc. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | Against | For |
| April 28, 2026 | The Brink's Company | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | Against | For |
| August 4, 2025 | Eagle Materials Inc. | Non-binding advisory stockholder proposal requesting the declassification of our Board of Directors. Shareholder proposal | For | Against |
| May 15, 2026 | Medpace Holdings, Inc. | Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposal | Against | For |
| July 23, 2025 | Booz Allen Hamilton Holding Corporation | Vote on a stockholder proposal regarding a report on political spending. Shareholder proposal | Against | For |
| June 15, 2026 | HubSpot, Inc. | A stockholder proposal to change the Company's Sixth Amended and Restated Bylaws to allow 10% holders of the Company's stock the ability to call a special meeting; and Shareholder proposal | For | Against |
| June 3, 2026 | Power Integrations, Inc. | To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposal | Against | For |
2,659 ballot items at 320 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund (PRDSX) voted at 320 shareholder meetings of 315 companies, on 2,659 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 10 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (89.7% against 93.7%). It voted differently from most T. Rowe Price funds on 53 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.